Bionano Genomics, Inc. (BNGO)
NASDAQ: BNGO · IEX Real-Time Price · USD
0.586
-0.010 (-1.60%)
Jul 22, 2024, 10:06 AM EDT - Market open
Bionano Genomics Employees
Bionano Genomics had 344 employees as of December 31, 2023. The number of employees decreased by 61 or -15.06% compared to the previous year.
Employees
344
Change (1Y)
-61
Growth (1Y)
-15.06%
Revenue / Employee
$108,924
Profits / Employee
-$659,276
Market Cap
49.70M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Inotiv | 2,055 |
Apyx Medical | 252 |
NextCure | 82 |
DURECT | 58 |
Modular Medical | 40 |
Lantern Pharma | 21 |
vTv Therapeutics | 16 |
Reneo Pharmaceuticals | 8 |
BNGO News
- 13 days ago - Bionano Announces Closing of up to $30 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules - GlobeNewsWire
- 17 days ago - Bionano Announces up to $30 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules - GlobeNewsWire
- 20 days ago - Scientific Presentations Highlight OGM's Utility for Cancer Research at Joint Annual Meeting for Three Molecular and Cytogenetic Associations - GlobeNewsWire
- 4 weeks ago - Bionano Announces Software Marketing Agreement with Revvity for Newborn Sequencing Research - GlobeNewsWire
- 4 weeks ago - Bionano Laboratories Announces New Category I CPT Code for OGM Use in Hematological Malignancy Analysis - GlobeNewsWire
- 2 months ago - Bionano Reports First Quarter 2024 Results and Highlights Recent Business Progress - GlobeNewsWire
- 3 months ago - Bionano Announces Publication Showing that OGM Detects Over 1250 Structural Variants, including 56 Gene Fusions, in Pediatric Leukemia that were Missed by Whole Genome Sequencing - GlobeNewsWire
- 3 months ago - Bionano Announces $10 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules - GlobeNewsWire